The dig might have uncovered some of the earliest victims of the Black Death, and other tantalizing clues about medieval life in the citadel. The Chapel Royal of St Peter ad Vincula at the Tower of ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

HANOI, Dec 11 (Reuters) - Industrial plants in the Vietnamese capital of Hanoi have come under renewed pressure to scale back their operations as authorities respond to a week of heavy and hazardous ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

LONDON — The Tower of London was closed after a video appeared to show activists smearing food on a display case containing one of Britain’s crown jewels. Police said four protesters had been arrested ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...

The developers of Tower of Fantasy had a live Q&A in which they detailed the new Warp servers. Announced a few months ago, the Warp servers will gut Tower of Fantasy’s gacha mechanics, and brings back ...

Dima Tower, 24, is on trial for two counts of first-degree murder in the stabbing deaths of his adoptive parents in August 2023. Prosecutors allege Tower stabbed his parents over 140 times, citing ...

A Ukrainian adoptee wept in court as his lawyer detailed his troubled life before he allegedly slaughtered his “caring” American parents. Dima Tower’s audible sobs filled the courtroom in Sarasota, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Julio is a Senior Author for Collider. He studied History and International Relations at university, but found his calling in cultural journalism. When he isn't writing, Julio also teaches English at ...